252 related articles for article (PubMed ID: 31921858)
1. Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.
Markkanen E
Front Cell Dev Biol; 2019; 7():348. PubMed ID: 31921858
[TBL] [Abstract][Full Text] [Related]
2. Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma.
Amini P; Nassiri S; Ettlin J; Malbon A; Markkanen E
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31308057
[TBL] [Abstract][Full Text] [Related]
3. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components.
Amini P; Nassiri S; Malbon A; Markkanen E
Sci Rep; 2020 Mar; 10(1):5506. PubMed ID: 32218455
[TBL] [Abstract][Full Text] [Related]
4. Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue.
Pöschel A; Beebe E; Kunz L; Amini P; Guscetti F; Malbon A; Markkanen E
Neoplasia; 2021 Apr; 23(4):400-412. PubMed ID: 33794398
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas.
Ettlin J; Bauer A; Opitz L; Malbon A; Markkanen E
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):14. PubMed ID: 37391533
[TBL] [Abstract][Full Text] [Related]
7. An optimised protocol for isolation of RNA from small sections of laser-capture microdissected FFPE tissue amenable for next-generation sequencing.
Amini P; Ettlin J; Opitz L; Clementi E; Malbon A; Markkanen E
BMC Mol Biol; 2017 Aug; 18(1):22. PubMed ID: 28835206
[TBL] [Abstract][Full Text] [Related]
8. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in Canine Mammary Tumors: Upregulation of miR-18a and miR-18b Oncogenes Is Associated with Decreased
Abbate JM; Arfuso F; Riolo K; Capparucci F; Brunetti B; Lanteri G
Animals (Basel); 2023 Mar; 13(6):. PubMed ID: 36978627
[TBL] [Abstract][Full Text] [Related]
11. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression.
Lutful Kabir FM; Alvarez CE; Bird RC
Vet Sci; 2015 Dec; 3(1):. PubMed ID: 29056711
[TBL] [Abstract][Full Text] [Related]
12. LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells.
Lu B; Wu J; Chen H; Li S; Jia K
Vet Sci; 2022 Feb; 9(2):. PubMed ID: 35202335
[TBL] [Abstract][Full Text] [Related]
13. Modeling molecular development of breast cancer in canine mammary tumors.
Graim K; Gorenshteyn D; Robinson DG; Carriero NJ; Cahill JA; Chakrabarti R; Goldschmidt MH; Durham AC; Funk J; Storey JD; Kristensen VN; Theesfeld CL; Sorenmo KU; Troyanskaya OG
Genome Res; 2021 Feb; 31(2):337-347. PubMed ID: 33361113
[TBL] [Abstract][Full Text] [Related]
14. RT-qPCR Expression Profiles of Selected Oncogenic and Oncosuppressor miRNAs in Formalin-Fixed, Paraffin-Embedded Canine Mammary Tumors.
Abbate JM; Giannetto A; Arfuso F; Brunetti B; Lanteri G
Animals (Basel); 2022 Oct; 12(21):. PubMed ID: 36359024
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
16. Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation.
Figuerêdo SH; Neto RSC; Ferreira E; Cassali GD; Estrela-Lima A; Damasceno KA
Res Vet Sci; 2021 Nov; 140():56-63. PubMed ID: 34399281
[TBL] [Abstract][Full Text] [Related]
17. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
18.
Huskey ALW; McNeely I; Merner ND
Front Genet; 2021; 12():702889. PubMed ID: 34447411
[TBL] [Abstract][Full Text] [Related]
19. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.
Zhou C; Lin Z; Li X; Zhang D; Song P
Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
